Rheumatology · page 2

Obesity blunts the response to JAK inhibitors in rheumatoid arthritis

Individual patient data from 16 trials show JAK inhibitor benefit falling steadily as BMI rises, resistance training for knee osteoarthritis has a dose that works better than more, and a methylation assay predicts who will remit on methotrexate.